BlackBerry and BiTECH Team Up To Build Safe, Reliable Digital LCD Instrument Cluster For Changan's Newly Launched UNI-K SUV
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Champignon Brands, Inc. and Encourages Investors to Contact the Firm
Straightup Resources Receives Preliminary High-Resolution Magnetic Survey Results on its Red Lake Ferdinand Gold Project, Ontario
Universal PropTech Announces Purchase Order with a Value Ranging Between CAD $6.5 and $10 Million for Indoor Air Quality Equipment
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Champignon Brands Inc.
CAPTIVATE Study Shows an IMBRUVICA® Plus VENCLEXTA®/VENCLYXTO® Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia
Arizona Silver Exploration Announces Completion of the Q2 RC Drilling Program at Philadelphia Gold & Silver Property
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care
Pacsun Forges Forward in Digital Space with Strong Momentum as They Unveil Integrated Experiences on Roblox
Wednesday Deadline to Actively Participate in Champignon Brands Inc. Class Action -Bronstein, Gewirtz & Grossman, LLC
Canex Intersects 0.7 G/T Gold Over 16.8 Metres Within 0.3 G/T Gold Over 62.5 Metres Increases the Target Strike Potential By 550%
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
New Data on KEYTRUDA® Plus LENVIMA® Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell Carcinoma From Pivotal Phase 3 CLEAR/KEYNOTE-581 Trial Presented at 2021 ASCO Annual Meeting
Release - Energy Fuels to Present at LD Micro Invitational on Tuesday, June 8 2021 as Hall of Fame Presenter
BRAXF FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important June 9 Deadline in Securities Class Action - BRAXF, SHRMF
Greenlane Renewables Announces Filing of Base Shelf Prospectus to Replace Existing Base Shelf Prospectus and Expiry of Warrants
Results From Phase 2 CodeBreaK 100 Show LUMAKRAS Is The First And Only KRAS G12C Inhibitor With Overall Survival Data
Universal Proptech Expands Distribution of Air Sniper Products Across Canada & Exploring Sales into the United States
Kite's Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Earning Priority Review Designation
SHRMF Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Champignon Brands Inc. Shareholders of Class Action and Lead Plaintiff Deadline: June 9, 2021
SHRMF FINAL DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Champignon Brands Inc. - SHRMF
WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Trodelvy® Demonstrates Superior Outcomes to Standard of Care in Second-Line Treatment of Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study
Puma Exploration Reports Progress on Its 2021 Exploration Program at Williams Brook Gold Property in New Brunswick, Canada
Phase 2 Fight Trial Continues To Show Improved Overall Survival With Bemarituzumab Plus Chemotherapy In Patients With FGFR2b+ Gastric And Gastroesophageal Cancers
Results from IMBRUVICA® RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data in First-Line Chronic Lymphocytic Leukemia
"Samsara Luggage plans to continue and dramatically increase its sales in the coming year with the launch of its Next Gen line of luggage." - Authority Magazine
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
Mega Uranium Announces Further Investments in Toro Energy Ltd. and International Consolidated Uranium Inc.
3D Systems Corporation, Amdocs Limited, Champignon Brands, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
Bristol Myers Squibb Presents Data from CheckMate -648 Showing Opdivo plus Chemotherapy and Opdivo plus Yervoy Significantly Improved Overall Survival Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Merck's KEYTRUDA® Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma
LYNPARZA® Reduced the Risk of Invasive Disease Recurrence or Death by 42% Versus Placebo in Adjuvant Treatment of Patients With Germline BRCA Mutations and High-Risk HER2-Negative Early Breast Cancer in Phase 3 OlympiA Trial
SHRMF Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Champignon Brands Inc. Shareholders of Class Action and Lead Plaintiff Deadline: June 9, 2021